the addition of isdn not only to other standard and proven antianginal agents but also to calcium antagonists should prove to be a fruitful area for further clinical research benefiting patients with angina pectoris ( caused by either coronary artery spasm or occlusive coronary artery disease ) , hypertension , and congestive heart failure .
C0022252
isdn
C0018802
congestive heart failure